GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dignitana AB (OSTO:DIGN) » Definitions » Research & Development

Dignitana AB (OSTO:DIGN) Research & Development : kr0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Dignitana AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Dignitana AB's Research & Development for the three months ended in Mar. 2024 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.

Dignitana AB Research & Development Historical Data

The historical data trend for Dignitana AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dignitana AB Research & Development Chart

Dignitana AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dignitana AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Dignitana AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dignitana AB  (OSTO:DIGN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dignitana AB Research & Development Related Terms

Thank you for viewing the detailed overview of Dignitana AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Dignitana AB (OSTO:DIGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dignitana AB (OSTO:DIGN) » Definitions » Research & Development
Comparable Companies
XSAT:REDS OSTO:NOSA XSAT:PHI NGM:MCLR OSTO:CLS B OSTO:SCIB OSTO:ACARIX OSTO:IRRAS OSTO:ICO OSTO:ARCOMA ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
DIZTF:USA
Address
Traktorgranden 3, Lund, SWE, 226 60
Website
http://www.dignitana.com
Dignitana AB is a medical technology company, that develops, produces, and markets The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. Geographically, it derives a majority of revenue from the USA.

Dignitana AB (OSTO:DIGN) Headlines

No Headlines